Organization

University of North Carolina, Chapel Hill

70 clinical trials

Clinical trial
Brain Network Dynamics of Depression During Esketamine Treatment
Status: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
Dose Optimization of Caffeine in Neonates With Hypoxic-Ischemic Encephalopathy
Status: Not yet recruiting, Estimated PCD: 2026-12-01
Clinical trial
Effects of Semaglutide on Nicotine Intake and Smoking Lapse
Status: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
The BEST Trial: Biomarkers for Evaluating Spine Treatments
Status: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
Rifaximin for the Secondary Prevention of Recurrent Pouchitis
Status: Not yet recruiting, Estimated PCD: 2026-04-01
Clinical trial
A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome
Status: Completed, Estimated PCD: 2023-09-22
Clinical trial
Dupilumab for Eosinophilic Esophagitis With Severe Strictures (DESTRICT Study)
Status: Not yet recruiting, Estimated PCD: 2025-11-01
Clinical trial
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
Status: Recruiting, Estimated PCD: 2025-08-30
Clinical trial
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
Status: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
Neuroinflammatory Mechanisms Linking Chronic Stress to Motivational Deficits
Status: Completed, Estimated PCD: 2023-12-19
Clinical trial
Effect of Hypertonic Saline on Mucociliary Clearance in Non-CF Bronchiectasis
Status: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Role Of Sensitivity to neuroEndocrine Systems in Social Decisions
Status: Withdrawn, Estimated PCD: 2025-07-01
Clinical trial
Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women
Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Human Laboratory Screening of Semaglutide for Alcohol Use Disorder
Status: Completed, Estimated PCD: 2024-04-12
Clinical trial
Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy
Status: Terminated, Estimated PCD: 2022-06-15
Clinical trial
Evaluation of Endometriosis With 18F-fluoroestradiol PET / MRI
Status: Completed, Estimated PCD: 2022-07-11
Clinical trial
Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology
Status: Completed, Estimated PCD: 2023-03-01
Clinical trial
Red Blood Cell Survival Study: The Impact of Oxidative Stress on Erythrocyte Biology
Status: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
Status: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
Ulipristal Acetate for Use in Early Pregnancy Loss: A Phase 2 Pilot Feasibility Study
Status: Completed, Estimated PCD: 2023-01-03
Clinical trial
Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1
Status: Not yet recruiting, Estimated PCD: 2025-02-01
Clinical trial
Baseline Oral Health Study: UnCoVer the Connections to General Health
Status: Active (not recruiting), Estimated PCD: 2025-02-01